NAVCO Pharmaceuticals Inc (TSE:NAV) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Navco Pharmaceuticals Inc. has been granted a Health Canada license for a nanoparticle-based antimicrobial cream, expanding their product range with a novel skin protection option. The cream, which uses nano-silver for its germ-fighting properties, offers moisturizing benefits and is an alcohol-free alternative to sprays. It aligns with the growing dermocosmetics market, which is projected to see significant growth over the next decade.
For further insights into TSE:NAV stock, check out TipRanks’ Stock Analysis page.